10.06.21
Syneos Health has acquired RxDataScience, a healthcare-focused data analytics, data management and artificial intelligence (AI) company. Syneos gains technology-enabled, insights-powered solutions with the aim of accelerating performance across the product lifecycle – from lab to life.
RxDataScience’s scalable platform enables biopharma companies to transform vast volumes of data into strategic, actionable insights. Multidisciplinary teams of product managers, data scientists, engineers, developers and domain experts leveraging insights from providers, payers and patients contribute to RxDataScience’s innovative software solutions.
The acquisition brings advanced solutions that go beyond basic reporting to sophisticated Augmented Intelligent Insights and Biopharma Analytics platforms. RxDataScience’s product lifecycle solutions include scientific computing for R&D, patient journey, decentralized trials, RWE, predictive analytics and commercial market research. Additionally, RxDataScience offers an accelerated consulting-based model, providing an approach to rapidly develop and deliver advanced analytics solution prototypes in six-to-eight-weeks.
“This acquisition boosts our ability to deliver strategic insights and technology-enabled solutions that address our customers’ most complex data challenges,” said Alistair Macdonald, CEO, Syneos Health. “We are thrilled to welcome the RxDataScience team to the Syneos Health family. Combining our end-to-end services and deep behavioral and therapeutic expertise with their AI and data-science capabilities will generate customer strategies to accelerate product development and time to market.”
“RxDataScience has dedicated its first five years to building a vision, talent and technology that address challenges in data management, data science and AI faced by biopharma companies,” said Sayee Natarajan, CEO and Co-Founder, RxDataScience. “We’re excited to join Syneos Health, giving us a tremendous opportunity to scale our services, expand our market and offer solutions to a larger customer base. We’re particularly excited to be part of an ecosystem built on innovation and an entrepreneurial approach for delivering novel solutions and new capabilities to customers.”
RxDataScience’s scalable platform enables biopharma companies to transform vast volumes of data into strategic, actionable insights. Multidisciplinary teams of product managers, data scientists, engineers, developers and domain experts leveraging insights from providers, payers and patients contribute to RxDataScience’s innovative software solutions.
The acquisition brings advanced solutions that go beyond basic reporting to sophisticated Augmented Intelligent Insights and Biopharma Analytics platforms. RxDataScience’s product lifecycle solutions include scientific computing for R&D, patient journey, decentralized trials, RWE, predictive analytics and commercial market research. Additionally, RxDataScience offers an accelerated consulting-based model, providing an approach to rapidly develop and deliver advanced analytics solution prototypes in six-to-eight-weeks.
“This acquisition boosts our ability to deliver strategic insights and technology-enabled solutions that address our customers’ most complex data challenges,” said Alistair Macdonald, CEO, Syneos Health. “We are thrilled to welcome the RxDataScience team to the Syneos Health family. Combining our end-to-end services and deep behavioral and therapeutic expertise with their AI and data-science capabilities will generate customer strategies to accelerate product development and time to market.”
“RxDataScience has dedicated its first five years to building a vision, talent and technology that address challenges in data management, data science and AI faced by biopharma companies,” said Sayee Natarajan, CEO and Co-Founder, RxDataScience. “We’re excited to join Syneos Health, giving us a tremendous opportunity to scale our services, expand our market and offer solutions to a larger customer base. We’re particularly excited to be part of an ecosystem built on innovation and an entrepreneurial approach for delivering novel solutions and new capabilities to customers.”
